Lalita S Limaye

Title: Lalita S Limaye: Innovator in Hematopoietic Stem Cell Preservation

Introduction

Lalita S Limaye is a notable inventor based in Pune, India. She has made significant contributions to the field of clinical hematology, particularly in the preservation of human hematopoietic stem or progenitor cells. Her innovative work has the potential to impact clinical practices and improve patient outcomes.

Latest Patents

Lalita S Limaye holds a patent for a method focused on the preservation of human hematopoietic stem or progenitor cells. The patent describes a technique for maintaining quiescent hematopoietic stem and progenitor cells (HSPC) in culture without the addition of exogenous growth factors. This method is crucial in clinical hematology, as it enhances the viability of stem cells for therapeutic applications. The research highlights the effectiveness of Flt3 receptor-interacting lectin (FRIL) and other mannose-binding lectins in preserving cord blood-derived progenitors in vitro. The study demonstrated that all four lectins examined maintained HSPC preservation activity for at least 30 days in culture, indicating a cost-effective approach for HSPC maintenance in clinical settings.

Career Highlights

Lalita S Limaye has worked with esteemed institutions such as the Department of Biotechnology and the Indian Institute of Science. Her career reflects a commitment to advancing scientific knowledge and practical applications in the field of hematology.

Collaborations

Lalita has collaborated with notable colleagues, including Vaijayanti P Kale and Ashwini Hinge. These partnerships have contributed to her research and the development of innovative solutions in her field.

Conclusion

Lalita S Limaye's work in the preservation of hematopoietic stem cells represents a significant advancement in clinical hematology. Her innovative methods and collaborations continue to pave the way for future research and applications in this vital area of medicine.